Dr. Talcott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2012 - 2015
- Brigham and Women's HospitalInternship, Internal Medicine, 2011 - 2012
- University of California San Francisco School of MedicineClass of 2011
Certifications & Licensure
- MA State Medical License 2015 - 2026
- OH State Medical License 2018 - 2025
- PA State Medical License 2016 - 2018
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Evaluation of Sustained Intraocular Pressure Elevations Across Antivascular Endothelial Growth Factor Agents.Neil A Rana, Meghana Chalasani, Jonathan Markle, Matthew W Russell, Ang Li
Journal of Vitreoretinal Diseases. 2024-12-13 - Predictors of Vision Loss After Lapse in Antivascular Endothelial Growth Factor Treatment in Patients With Diabetic Macular Edema.Meghana Chalasani, Christopher Maatouk, Jonathan Markle, Rishi P Singh, Katherine E Talcott
Journal of Vitreoretinal Diseases. 2024-12-13 - Risk of audiologic side effects with teprotumumab treatment for thyroid eye disease: propensity matched analysis.Jonathan C Markle, Anil Johanis, Jacqueline K Shaia, Daniel Benito, Katherine E Talcott
Eye. 2024-12-12
Press Mentions
- Spotlight on Expanded Field Imaging Findings in Proliferative Sickle Cell RetinopathySeptember 1st, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: